Key Market Segments:
By Product
-
-
Test Kit and Reagents
-
-
-
Instruments
-
Others
-
By End-use
-
-
Hospitals and clinic
-
-
-
Diagnostic Labs
-
Others
-
By Test
-
-
Traditional Influenza Diagnostic Tests
-
Rapid Influenza Diagnostic Tests (RIDTs)
-
Direct Fluorescent Antibody (DFA) Tests
-
Viral Culture
-
Serological Assays
-
-
-
-
Molecular Influenza Diagnostic Tests
-
Reverse Transcription Polymerase Chain Reaction (RT-PCR)
-
Isothermal Nucleic Acid Amplification Tests (INAAT)
-
Loop-Mediated Isothermal-based Amplification Assays
-
Transcription Mediated Isothermal-based Amplification Assays
-
-
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
-
Mexico
Europe
-
Eastern Europe
-
Poland
-
Romania
-
Hungary
-
Turkey
-
Rest of Eastern Europe
-
-
Western Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Netherlands
-
Switzerland
-
Austria
-
Rest of Western Europe
-
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Vietnam
-
Singapore
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
Middle East
-
UAE
-
Egypt
-
Saudi Arabia
-
Qatar
-
Rest of the Middle East
Africa
-
Nigeria
-
South Africa
-
Rest of Africa
Latin America
-
Brazil
-
Argentina
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Product Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Product Matrix which gives a detailed comparison of the product portfolio of each company
-
Geographic Analysis
-
Additional countries in any of the regions
-
Company Information
-
Detailed analysis and profiling of additional market players (Up to five)
Frequently Asked Questions
Variability in test accuracy and limited awareness and training among healthcare providers are significant challenges
Molecular influenza diagnostic tests are expected to grow at the highest CAGR of about 6.31% from 2024 to 2032.
The ongoing rate of infectious diseases and increasing demand for effective diagnostic solutions are key drivers.
Influenza Diagnostics Market was valued at USD1.49 billion in 2023 and is expected to reach USD 2.45 billion by 2032, growing at a CAGR of 5.69 % from 2024-2032.